Company Profile

SciBase Holding AB is a Sweden-based company engaged in the medical equipment industry. The Company specializes in the manufacture of point of care device, called Nevisense, which is aimed to detect of malignant melanoma. Nevisense analyze suspicious lesions by using Electrical Impedance Spectroscopy (EIS) which is applied as an electrical signal to the skin. The diagnostic product is sold in Nordic countries, Belgium, Germany, Great Britain and Australia.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

03-02	SciBase Wins US FDA Nod for Skin Cancer Detection Device Label Expansion	MT
11-07	SciBase, Castle Biosciences Expand License Deal, Secures SEK20 Million Loan	MT

03-02	SciBase Wins US FDA Nod for Skin Cancer Detection Device Label Expansion	MT
11-07	SciBase, Castle Biosciences Expand License Deal, Secures SEK20 Million Loan	MT
11-07	SciBase Plans Warrant Buyback; Mulls SEK83 Million Rights Issue	MT
23/09/25	SciBase Lands Point-of-care Platform Order Under Clinical Study Partnership	MT
10/09/25	SciBase's Shareholders Boost Stakes	MT
07/07/25	SciBase Wins New Order for Skin Cancer Diagnostic Platform in US	MT
24/06/25	SciBase to Raise SEK11 Million in Second Directed Share Issue	MT
17/06/25	SciBase Plans Up to SEK30 Million Equity Raise	MT
17/06/25	SciBase Signs Dermatological Diagnostic Tests Collaboration With Castle Biosciences	MT
05/06/25	Sweden's SciBase Receives First Italian Order	MT
30/01/25	Sweden's SciBase Onboards US Dermatology Practices	MT
13/11/24	Inderes raises target price for Scibase to SEK 0.45 (0.40), reiterates reduce - BN	FW
12/11/24	SciBase to Raise SEK82 Million via Directed, Rights Issue if UNits	MT

05-28	SciBase announces that the board of directors has resolved on the record date for the reverse share split	AQ
05-28	Nevisense detects skin barrier damage by chemicals used in household cleaning products in a new ex-vivo study	AQ
05-19	Bulletin from the annual general meeting in SciBase Holding AB (publ)	AQ
05-18	Scibase : Presentation proposed board of directors	PU
05-18	SciBase Announces New Research Highlighting Nevisense's Potential in Detecting Age-Related Skin Barrier Changes	AQ

Manager	Title	Age	Since
Pia Renaudin CEO	Chief Executive Officer	59	30/09/2023
Michael Colérus DFI	Director of Finance/CFO	64	31/12/2013
Jvalini Dwarkasing CTO	Chief Tech/Sci/R&D Officer	-	-

Director	Title	Age	Since
Anna Maria Albertina Eriksrud BRD	Director/Board Member	68	-
Jesper Høiland CHM	Chairman	65	12/06/2024
Diana Ferro BRD	Director/Board Member	60	15/05/2017

SciBase Holding AB (publ) Share Price

Stocks

Advanced Medical Equipment & Technology

Latest news : SciBase Holding AB (publ)

Analysts' recommendations: SciBase Holding AB (publ)

Press Releases: SciBase Holding AB (publ)

Managers and Directors: SciBase Holding AB (publ)

Medical Diagnostic & Testing Equipment

Company Profile

End-of-day quote Nasdaq Stockholm Other stock markets
- ^SEK	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SARTORIUS AG	+1.46%	+2.68%	+4.93%	-25.89%	16.36B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	-4.23%	+13.31%	+39.95%	+97.00%	1.78B
QUIDELORTHO CORPORATION	-1.37%	-1.26%	-40.38%	-78.19%	1.24B
ECKERT & ZIEGLER SE	-0.31%	+3.80%	-28.39%	+37.99%	1.14B
CONTEC MEDICAL SYSTEMS CO.,LTD	0.00%	+1.60%	-25.50%	-52.75%	640M
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-2.22%	-4.47%	-38.00%	-56.03%	582M
VAREX IMAGING CORPORATION	+1.23%	+7.62%	+22.05%	-53.18%	447M
REVENIO GROUP OYJ	-0.32%	+0.32%	-55.36%	-59.44%	382M
CELLAVISION AB	-2.05%	+5.91%	-22.07%	-20.86%	362M
Average	-0.87%	+3.47%	-15.86%	-23.48%	2.55B
Weighted average by Cap.	+0.55%	+3.29%	+0.51%	-18.52%